DocGo (DCGO)
Delivers medical transportation, mobile care, and virtual care outside traditional clinics.
DocGo Q2 Earnings Call Highlights
DocGo NASDAQ: DCGO reported second-quarter revenue of $73.4 million, down from $80.4 million a year earlier, as the company continued to wind down migrant-related projects. Excluding migrant-related revenue, revenue rose 19% year over year, while revenue from business lines operating in both periods increased about 5% after also excluding contributions from the SteadyMD acquisition.
DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript
DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript
DocGo Inc. (DCGO) Surpasses Q2 Earnings Estimates
DocGo Inc. (DCGO) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.11 per share a year ago.
DocGo Announces Second Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Total revenue for the second quarter of 2026 was $73.4 million, compared to $80.4 million in the second quarter of 2025. This decline was entirely due to the wind-down of migrant-related progra.
DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
DocGo Inc. (NASDAQ:DCGO) will release its second earnings report after the closing bell on Monday, Aug. 17.
DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the second quarter ended June 30, 2026 after the markets close on Monday, August 17, 2026. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, August 17, 2026 5:00.
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
DocGo Inc. (DCGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
DocGo Inc. (DCGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
DocGo Launches Mobile Phlebotomy Services in South Florida
DocGo Inc. (Nasdaq: DCGO) (âDocGoâ or the âCompanyâ), a leading provider of technology-enabled mobile health and medical transportation services, today
DocGo Launches Mobile Phlebotomy Services in South Florida
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its PTI Health by DocGo subsidiary has launched mobile phlebotomy services in Southern Florida. In conjunction with this launch, PTI Health has expanded its relationship with a major national clinical laboratory to cover services throughout the Southeast and will work collaboratively with this lab partne.
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport
DocGo NASDAQ: DCGO Chief Executive Officer Lee Bienstock outlined the company's transition away from COVID-related, migrant and emergency-response programs and toward its “evergreen” medical transportation and mobile health businesses during a presentation at the 21st Annual Needham Technology, Media, and Consumer Conference.
DocGo Inc. (DCGO) Q1 2026 Earnings Call Transcript
DocGo Inc. (DCGO) Q1 2026 Earnings Call Transcript
DocGo Q1 Earnings Call Highlights
DocGo NASDAQ: DCGO reported first-quarter revenue of $75.6 million and an adjusted EBITDA loss of $10.2 million, as executives pointed to accelerating demand in virtual care, medical transportation and mobile health services while acknowledging pressure from fuel costs and labor-related investments.
DocGo Inc. (DCGO) Reports Q1 Loss, Beats Revenue Estimates
DocGo Inc. (DCGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.09 per share a year ago.
DocGo Announces First Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Total revenue for the first quarter of 2026 was $75.6 million, compared to $96.0 million in the first quarter of 2025. This decline was entirely due to the wind-down of migrant-related programs,.
DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will deliver a company presentation at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, at 11:45 – 12:25 PM Eastern Time, and will be participating in 1x1 meetings at this event. A webcast of the presentation will be available on the investo.
DocGo to Announce First Quarter 2026 Results on Monday, May 11, 2026
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31, 2026 after the markets close on Monday, May 11, 2026. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, May 11, 2026 5:00 p.m.
Analysts Set DocGo Inc. (NASDAQ:DCGO) PT at $2.38
Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have earned an average rating of "Hold" from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company.
Head-To-Head Survey: DocGo (NASDAQ:DCGO) vs. CochLear (OTCMKTS:CHEOY)
DocGo (NASDAQ: DCGO - Get Free Report) and CochLear (OTCMKTS:CHEOY - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Analyst Recommendations This is a summary of recent ratings and
Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies®
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has been recognized as one of the 2026 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This is DocGo's first time receiving this honor, and the Company is one of only four honorees in the healthcare providers and ser.